360 related articles for article (PubMed ID: 9694973)
21. Ontogenic increase in PGE2 and PGF2 alpha receptor density in brain microvessels of pigs.
Li DY; Varma DR; Chemtob S
Br J Pharmacol; 1994 May; 112(1):59-64. PubMed ID: 8032662
[TBL] [Abstract][Full Text] [Related]
22. Effects of bradykinin on signal transduction, cell proliferation, and cytokine, prostaglandin E2 and collagenase-1 release from human corneal epithelial cells.
Wiernas TK; Davis TL; Griffin BW; Sharif NA
Br J Pharmacol; 1998 Mar; 123(6):1127-37. PubMed ID: 9559896
[TBL] [Abstract][Full Text] [Related]
23. Intraocular pressure effects of selective prostanoid receptor agonists involve different receptor subtypes according to radioligand binding studies.
Woodward DF; Lawrence RA; Fairbairn CE; Shan T; Williams LS
J Lipid Mediat; 1993; 6(1-3):545-53. PubMed ID: 8358015
[TBL] [Abstract][Full Text] [Related]
24. Radioligand binding analysis of receptor subtypes in two FP receptor preparations that exhibit different functional rank orders of potency in response to prostaglandins.
Woodward DF; Fairbairn CE; Krauss AH; Lawrence RA; Protzman CE
J Pharmacol Exp Ther; 1995 Apr; 273(1):285-7. PubMed ID: 7714778
[TBL] [Abstract][Full Text] [Related]
25. Characterization of [3H]-prostaglandin E2 binding to prostaglandin EP4 receptors expressed with Semliki Forest virus.
Marshall FH; Patel K; Lundstrom K; Camacho J; Foord SM; Lee MG
Br J Pharmacol; 1997 Aug; 121(8):1673-8. PubMed ID: 9283702
[TBL] [Abstract][Full Text] [Related]
26. Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: focus on DP class prostanoids.
Sharif NA; Crider JY; Xu SX; Williams GW
J Pharmacol Exp Ther; 2000 May; 293(2):321-8. PubMed ID: 10772998
[TBL] [Abstract][Full Text] [Related]
27. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.
Regan JW; Bailey TJ; Pepperl DJ; Pierce KL; Bogardus AM; Donello JE; Fairbairn CE; Kedzie KM; Woodward DF; Gil DW
Mol Pharmacol; 1994 Aug; 46(2):213-20. PubMed ID: 8078484
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin E receptor subtypes involved in stimulation of gastroduodenal bicarbonate secretion in rats and mice.
Takeuchi K; Ukawa H; Furukawa O; Kawauchi S; Araki H; Sugimoto Y; Ishikawa A; Ushikubi F; Narumiya S
J Physiol Pharmacol; 1999 Jun; 50(2):155-67. PubMed ID: 10424714
[TBL] [Abstract][Full Text] [Related]
29. Fewer PGE2 and PGF2 alpha receptors in brain synaptosomes of newborn than of adult pigs.
Li DY; Varma DR; Chatterjee TK; Fernandez H; Abran D; Chemtob S
J Pharmacol Exp Ther; 1993 Dec; 267(3):1292-7. PubMed ID: 8263792
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E2 binding sites in human renal tissue: characterization and localization by radioligand binding and autoradiography.
Eriksson LO; Larsson B; Hedlund H; Andersson KE
Acta Physiol Scand; 1990 Jul; 139(3):393-404. PubMed ID: 2173350
[TBL] [Abstract][Full Text] [Related]
31. Identification of prostanoid receptors in rabbit non-pigmented ciliary epithelial cells.
Bhattacherjee P; Jacobs N; Coca-Prados M; Paterson C
Exp Eye Res; 1996 May; 62(5):491-8. PubMed ID: 8759517
[TBL] [Abstract][Full Text] [Related]
32. Increases in retinovascular prostaglandin receptor functions by cyclooxygenase-1 and -2 inhibition.
Hardy P; Bhattacharya M; Abran D; Peri KG; Asselin P; Varma DR; Chemtob S
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1888-98. PubMed ID: 9727412
[TBL] [Abstract][Full Text] [Related]
33. AL-3138 antagonizes FP prostanoid receptor-mediated inositol phosphates generation: comparison with some purported FP antagonists.
Sharif NA; Crider JY; Davis TL
J Pharm Pharmacol; 2000 Dec; 52(12):1529-39. PubMed ID: 11197083
[TBL] [Abstract][Full Text] [Related]
34. AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor.
Griffin BW; Klimko P; Crider JY; Sharif NA
J Pharmacol Exp Ther; 1999 Sep; 290(3):1278-84. PubMed ID: 10454504
[TBL] [Abstract][Full Text] [Related]
35. Prostanoid receptors of the EP3 subtype mediate inhibition of evoked [3H]acetylcholine release from isolated human bronchi.
Reinheimer T; Harnack E; Racke K; Wessler I
Br J Pharmacol; 1998 Sep; 125(2):271-6. PubMed ID: 9786498
[TBL] [Abstract][Full Text] [Related]
36. Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease.
Li SR; Yang Q; Koller E; Kurtaran A; Bischof C; Leimer M; Rauscha F; Pidlich J; Virgolini I
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2066-73. PubMed ID: 9351373
[TBL] [Abstract][Full Text] [Related]
37. Preferential binding of the novel prostaglandin SC-46275 to canine gastric versus intestinal receptors.
Tsai BS; Keith RH; Perkins WE; Walsh RE; Anglin CP; Collins PW; Gasiecki AW; Bauer RF; Jones PH; Gaginella TS
J Pharmacol Exp Ther; 1995 Oct; 275(1):368-73. PubMed ID: 7562572
[TBL] [Abstract][Full Text] [Related]
38. Prostaglandin E2 binding site distribution and subtype classification in the rabbit iris-ciliary body.
Csukas S; Bhattacherjee P; Rhodes L; Paterson CA
Prostaglandins; 1992 Sep; 44(3):199-208. PubMed ID: 1329153
[TBL] [Abstract][Full Text] [Related]
39. Cat iris sphincter smooth-muscle contraction: comparison of FP-class prostaglandin analog agonist activities.
Sharif NA; Kaddour-Djebbar I; Abdel-Latif AA
J Ocul Pharmacol Ther; 2008 Apr; 24(2):152-63. PubMed ID: 18355130
[TBL] [Abstract][Full Text] [Related]
40. Temporal and tissue-specific expression of prostaglandin receptors EP2, EP3, EP4, FP, and cyclooxygenases 1 and 2 in uterus and fetal membranes during bovine pregnancy.
Arosh JA; Banu SK; Chapdelaine P; Fortier MA
Endocrinology; 2004 Jan; 145(1):407-17. PubMed ID: 14500566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
